DCGI to fast-track approval for Covid-19 drug, vaccine

The DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal study and offering flexible pathways which earlier would have taken months. It said applications from companies will be given “high priority” and that it will assist the companies in speeding up their research.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39hWcC4
via IFTTT